HPC
HOLX

HM Payson & Co’s Hologic HOLX Stock Holding History

HM Payson & Co’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,310
Closed -$326K – 1161
2026
Q1 		$326K Sell
4,310
-4,043
-48% -$304K ﹤0.01% 360
2025
Q4 		$622K Sell
8,353
-2,129
-20% -$156K 0.01% 270
2025
Q3 		$707K Buy
10,482
+272
+3% +$18.1K 0.01% 251
2025
Q2 		$665K Hold
10,210
– – 0.01% 249
2025
Q1 		$631K Hold
10,210
– – 0.01% 257
2024
Q4 		$736K Sell
10,210
-2
-0% -$156 0.01% 239
2024
Q3 		$832K Sell
10,212
-112
-1% -$8.96K 0.01% 232
2024
Q2 		$767K Hold
10,324
– – 0.01% 231
2024
Q1 		$805K Hold
10,324
– – 0.02% 230
2023
Q4 		$738K Sell
10,324
-20
-0.2% -$1.39K 0.02% 235
2023
Q3 		$718K Hold
10,344
– – 0.02% 232
2023
Q2 		$838K Hold
10,344
– – 0.02% 209
2023
Q1 		$835K Hold
10,344
– – 0.02% 205
2022
Q4 		$774K Hold
10,344
– – 0.02% 209
2022
Q3 		$667K Hold
10,344
– – 0.02% 218
2022
Q2 		$717K Hold
10,344
– – 0.02% 218
2022
Q1 		$795K Sell
10,344
-378
-4% -$27.2K 0.02% 223
2021
Q4 		$821K Buy
10,722
+582
+6% +$42.8K 0.02% 229
2021
Q3 		$748K Hold
10,140
– – 0.02% 229
2021
Q2 		$677K Hold
10,140
– – 0.02% 240
2021
Q1 		$754K Buy
10,140
+20
+0.2% +$1.52K 0.02% 231
2020
Q4 		$737K Hold
10,120
– – 0.02% 235
2020
Q3 		$673K Buy
10,120
+1,942
+24% +$123K 0.02% 226
2020
Q2 		$466K Hold
8,178
– – 0.02% 237
2020
Q1 		$287K Hold
8,178
– – 0.01% 268
2019
Q4 		$427K Hold
8,178
– – 0.01% 275
2019
Q3 		$413K Hold
8,178
– – 0.01% 280
2019
Q2 		$393K Buy
+8,178
New +$378K 0.01% 295
2018
Q4 		– Sell
-8,328
Closed -$341K – 228
2018
Q3 		$341K Sell
8,328
-190
-2% -$7.68K 0.02% 259
2018
Q2 		$339K Buy
8,518
+190
+2% +$7.31K 0.01% 260
2018
Q1 		$311K Hold
8,328
– – 0.01% 267
2017
Q4 		$356K Hold
8,328
– – 0.01% 268
2017
Q3 		$306K Hold
8,328
– – 0.01% 267
2017
Q2 		$378K Hold
8,328
– – 0.02% 255
2017
Q1 		$354K Hold
8,328
– – 0.02% 253
2016
Q4 		$334K Hold
8,328
– – 0.02% 255
2016
Q3 		$323K Hold
8,328
– – 0.02% 251
2016
Q2 		$288K Sell
8,328
-100
-1% -$3.46K 0.01% 266
2016
Q1 		$291K Sell
8,428
-2,733
-24% -$95.3K 0.02% 260
2015
Q4 		$432K Buy
11,161
+2,733
+32% +$106K 0.02% 229
2015
Q3 		$330K Hold
8,428
– – 0.02% 241
2015
Q2 		$321K Sell
8,428
-600
-7% -$21K 0.02% 252
2015
Q1 		$298K Hold
9,028
– – 0.01% 256
2014
Q4 		$241K Sell
9,028
-1,060
-11% -$27.4K 0.01% 276
2014
Q3 		$245K Sell
10,088
-325
-3% -$8.21K 0.01% 265
2014
Q2 		$264K Sell
10,413
-100
-1% -$2.34K 0.01% 257
2014
Q1 		$227K Sell
10,513
-4,400
-30% -$94.9K 0.01% 267
2013
Q4 		$333K Sell
14,913
-2,128
-12% -$46.9K 0.02% 236
2013
Q3 		$352K Sell
17,041
-15,431
-48% -$328K 0.02% 232
2013
Q2 		$627K Buy
+32,472
New +$678K 0.04% 188

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HM Payson & Co's HOLX Position: Q2 2026 in Review

HM Payson & Co sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,310 shares — an estimated $326K sold.

HM Payson & Co first reported a position in HOLX in Q2 2013 and held it in 50 quarters. The position peaked at $838K in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • HM Payson & Co reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • HM Payson & Co sold 4,310 Hologic shares in Q2 2026, an estimated $326K.
  • HM Payson & Co first reported a position in Hologic in Q2 2013 and held it in 50 quarters.
  • HM Payson & Co's Hologic position peaked at $838K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.